Normohamadpur Pedram, Ghaedi Forugh
Razi Hospital, Vahdat Eslami Street, Tehran, Iran.
Iran J Parasitol. 2018 Jan-Mar;13(1):156-160.
Although leishmaniasis is an endemic disease in Iran the mucosal involvement is rare. Mucocutaneous leishmaniasis (MCL) mainly caused by infection, reported with other species such as . Herein a 78 yr old man with MCL from Iran is presented who referred to Razi Hospital Dermatology Clinic, Tehran, Iran, for multiple ulcerative lesions on mid face skin, mucosa of upper lip and anterior fossa of nose, dorsal aspect of the hands and the posterior aspect of heels. Skin biopsy revealed necrotizing and granulomatous tissue pattern that suggested infection pathogenesis but the smear for leishmaniasis, spp, and fungal elements was negative at first. In order to a positive PPD test, he was treated by anti-tuberculosis treatment. A month after starting drugs for tuberculosis, the prepared microscopical smears were positive for Leishman bodies this time. The skin biopsy revealed amastigote forms of sp. and the PCR assay on specimens of lesions proved as the principal pathogenic agent. There was good response to systemic treatment with meglumine antimoniate (Glucantime®) 3 gr per day until one week followed by 4.5 gr per day for another week. We forced to discontinue of drug because of cardiac toxicity at the end of 2 wk of treatment.
尽管利什曼病在伊朗是一种地方病,但黏膜受累情况罕见。皮肤黏膜利什曼病(MCL)主要由感染引起,有报告称还与其他物种有关,如 。本文介绍了一名来自伊朗的78岁MCL患者,他因面部中部皮肤、上唇黏膜、鼻前窝、手背和足跟后部出现多处溃疡性病变,前往伊朗德黑兰拉齐医院皮肤科诊所就诊。皮肤活检显示坏死性和肉芽肿性组织模式,提示感染发病机制,但最初利什曼病、 spp和真菌成分的涂片均为阴性。由于PPD试验呈阳性,他接受了抗结核治疗。开始抗结核药物治疗一个月后,此次制备的显微镜涂片利什曼小体呈阳性。皮肤活检显示 sp. 的无鞭毛体形式,病变标本的PCR检测证明 是主要病原体。每天使用3克葡甲胺锑酸盐(Glucantime®)进行全身治疗,直至一周,随后再以每天4.5克的剂量治疗一周,治疗效果良好。在治疗2周结束时,由于心脏毒性,我们被迫停药。